Literature DB >> 8834172

Novel mitochondrial DNA deletion found in a renal cell carcinoma.

T M Horton1, J A Petros, A Heddi, J Shoffner, A E Kaufman, S D Graham, T Gramlich, D C Wallace.   

Abstract

Polymerase chain reaction (PCR) was used to analyze a rarely deleted region of mitochondrial DNA (mtDNA) from 39 human renal cell carcinomas (RCC) and matched normal kidney tissue removed during radical nephrectomy. One tumor specimen (E.R.) had a unique PCR product approximately 250 base pairs (bp) smaller than the PCR product found in the normal E.R. kidney. Sequence analysis of the tumor-specific PCR fragment revealed a 264 bp deletion in the first subunit (NDI) of NADH:ubiquinone oxidoreductase (complex I) of the electron transport chain. Southern analysis of the RCCs demonstrated that approximately 50% of the mtDNA molecules in the primary RCC contained a unique 3.2 kb EcoRV restriction fragment found only in E.R. tumor mtDNA. Northern analysis demonstrated preferential transcription of the truncated NDI mRNA. None of the five metastases or any normal tissue from E.R. contained levels of the NDI deletion detectable by PCR. This is the first reported case of an intragenic NDI mtDNA deletion.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8834172     DOI: 10.1002/(SICI)1098-2264(199602)15:2<95::AID-GCC3>3.0.CO;2-Z

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  41 in total

1.  The age-related accumulation of a mitochondrial DNA control region mutation in muscle, but not brain, detected by a sensitive PNA-directed PCR clamping based method.

Authors:  D G Murdock; N C Christacos; D C Wallace
Journal:  Nucleic Acids Res       Date:  2000-11-01       Impact factor: 16.971

2.  HPV-DNA integration and carcinogenesis: putative roles for inflammation and oxidative stress.

Authors:  Vonetta M Williams; Maria Filippova; Ubaldo Soto; Penelope J Duerksen-Hughes
Journal:  Future Virol       Date:  2011-01-01       Impact factor: 1.831

3.  Age related somatic mitochondrial DNA deletions in bone.

Authors:  S S Papiha; H Rathod; I Briceno; J Pooley; H K Datta
Journal:  J Clin Pathol       Date:  1998-02       Impact factor: 3.411

Review 4.  Mitochondrial dysfunction and mitochondrial dynamics-The cancer connection.

Authors:  Satish Srinivasan; Manti Guha; Anna Kashina; Narayan G Avadhani
Journal:  Biochim Biophys Acta Bioenerg       Date:  2017-01-16       Impact factor: 3.991

5.  Renal cell carcinoma in a pediatric patient with an inherited mitochondrial mutation.

Authors:  Surasak Sangkhathat; Takeshi Kusafuka; Akihiro Yoneda; Seika Kuroda; Yukichi Tanaka; Mio Tanaka; Norio Sakai; Masahiro Fukuzawa
Journal:  Pediatr Surg Int       Date:  2005-10-20       Impact factor: 1.827

6.  mtDNA lineage analysis of mouse L-cell lines reveals the accumulation of multiple mtDNA mutants and intermolecular recombination.

Authors:  Weiwei Fan; Chun Shi Lin; Prasanth Potluri; Vincent Procaccio; Douglas C Wallace
Journal:  Genes Dev       Date:  2012-02-15       Impact factor: 11.361

7.  Mitochondrial DNA determines androgen dependence in prostate cancer cell lines.

Authors:  M Higuchi; T Kudo; S Suzuki; T T Evans; R Sasaki; Y Wada; T Shirakawa; J R Sawyer; A Gotoh
Journal:  Oncogene       Date:  2006-03-09       Impact factor: 9.867

8.  Mitochondrial DNA mutation stimulates prostate cancer growth in bone stromal environment.

Authors:  Rebecca S Arnold; Carrie Q Sun; Jendai C Richards; Galina Grigoriev; Ilsa M Coleman; Peter S Nelson; Chia-Ling Hsieh; Jae K Lee; Zhiheng Xu; Andre Rogatko; Adeboye O Osunkoya; Majd Zayzafoon; Leland Chung; John A Petros
Journal:  Prostate       Date:  2009-01-01       Impact factor: 4.104

9.  Activation of Akt is essential for the propagation of mitochondrial respiratory stress signaling and activation of the transcriptional coactivator heterogeneous ribonucleoprotein A2.

Authors:  Manti Guha; Ji-Kang Fang; Robert Monks; Morris J Birnbaum; Narayan G Avadhani
Journal:  Mol Biol Cell       Date:  2010-08-18       Impact factor: 4.138

10.  Novel HPMA copolymer-bound constructs for combined tumor and mitochondrial targeting.

Authors:  Vaikunth Cuchelkar; Pavla Kopecková; Jindrich Kopecek
Journal:  Mol Pharm       Date:  2008-09-04       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.